Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-30
2007-01-30
Dentz, Bernard (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S010000, C549S011000, C549S014000, C549S022000, C549S030000, C549S039000, C549S347000
Reexamination Certificate
active
10850588
ABSTRACT:
1′-substituted cannabinoid derivatives of delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, and delta-6a-10a-tetrahydrocannabinol that have affinity for the cannabinoid receptor type-1 (CB-1) and/or cannabinoid receptor type-2 (CB-2). Compounds having activity as either agonists or antagonists of the CB-1 and/or CB-2 receptors can be used for treating CB-1 or CB-2 mediated conditions.
REFERENCES:
patent: 3901926 (1975-08-01), Winn et al.
patent: 3915996 (1975-10-01), Wright et al.
patent: 3941782 (1976-03-01), Harris et al.
patent: 5747524 (1998-05-01), Cullinan et al.
patent: 5939429 (1999-08-01), Kunos et al.
patent: 5948777 (1999-09-01), Bender et al.
patent: 6100259 (2000-08-01), Xiang et al.
patent: 6284788 (2001-09-01), Mittendorf et al.
patent: 6344474 (2002-02-01), Maruani et al.
patent: 6448288 (2002-09-01), Burstein et al.
patent: 6509367 (2003-01-01), Martin et al.
patent: 6563009 (2003-05-01), Kunos et al.
patent: 6610737 (2003-08-01), Garzon et al.
patent: 6642258 (2003-11-01), Bourrie et al.
patent: 6653304 (2003-11-01), Leftheris et al.
patent: 6939977 (2005-09-01), Makriyannis et al.
patent: 2001/0034344 (2001-10-01), Mittendorf et al.
patent: 2002/0022653 (2002-02-01), Burstein et al.
patent: 2002/0119972 (2002-08-01), Leftheris et al.
patent: 2002/0173528 (2002-11-01), Fride et al.
patent: 2003/0087933 (2003-05-01), Blanchard et al.
patent: 2003/0096844 (2003-05-01), Kozlowski et al.
patent: 2003/0232859 (2003-12-01), Kozlowski et al.
patent: 2004/0010013 (2004-01-01), Friary et al.
patent: 2004/0039048 (2004-02-01), Guzman Pastor et al.
patent: 2004/0044051 (2004-03-01), Kozlowski et al.
patent: 2004/0077650 (2004-04-01), Dow
Bailey et al, J. of Chromatography, vol. 87,p.263-266 (1973).
Papahatjis et al, J. of Heterocyclic Chem., vol. 33, p. 559-562 (1996).
Keimowitz et al., “QSAR Analysis of Δ8-THC Analogues: Relationship of Side-Chain Conformation to Cannabinoid Receptor Affinity and Pharmacological Potency,”J. Med. Chem.43:59-70 (2000).
Papahatjis et al., “Pharmacophoric Requirements for the Cannabinoid Side Chain Probing the Cannabinoid Receptor Subsite at C1,”J. Med. Chem.46:3221-3229 (2003).
Krishnamurthy, Mathangi, “Probing The Ligand-Binding Pocket Of The Cannabinoid Receptors: Design and Synthesis of Novel Ligands,” A Dissertation Presented for The Graduate Studies Counsel, The University of Tennessee Health Science Center; pp. 176-178, Dec. 2005.
Krishnamurthy et al., “Synthesis And Testing of Novel Phenyl Substituted Side-Chain Analogues of Classical Cannabinoids,” Bioorganic & Medicinal Chemistry Letters 13 (2003); 3487-3490.
Nadipuram, et al., “Synthesis And Testing Of Novel Classical Cannabinoids: Exploring The Side Chain Ligand Binding Pocket Of The CB1 and CB2 Receptors,” Bioorganic & Medicinal Chemistry 11 (2003); 3121-3132.
Ferreira Antonio M.
Krishnamurthy Mathangi
Moore, II Bob M.
Dentz Bernard
O'Melveny & Myers LLP
University of Tennessee Research Foundation
LandOfFree
Cannabinoid derivatives, methods of making, and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cannabinoid derivatives, methods of making, and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cannabinoid derivatives, methods of making, and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3734944